Search Results - Fagery, Mussab

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey

    Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey by Glewis, Sarah, Krishnasamy, Mei, Lingaratnam, Senthil, Harris, Sam, Underhill, Craig, Georgiou, Chloe, Warren, Mark, Campbell, Robert, IJzerman, Maarten, Fagery, Mussab, Campbell, Ian, Martin, Jennifer H., Tie, Jeanne, Alexander, Marliese, Michael, Michael

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Pharmacogenetic‐guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A128) chemotherapies for patients with cancer (PACIFIC‐PGx): A multicenter clinical trial

    Pharmacogenetic‐guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A128) chemotherapies for patients with cancer (PACIFIC‐PGx): A multicenter clinical trial by Glewis, Sarah, Lingaratnam, Senthil, Lee, Benjamin, Campbell, Ian, IJzerman, Maarten, Fagery, Mussab, Harris, Sam, Georgiou, Chloe, Underhill, Craig, Warren, Mark, Campbell, Robert, Jayawardana, Madawa, Silva, S. Sandun M., Martin, Jennifer H., Tie, Jeanne, Alexander, Marliese, Michael, Michael

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review

    Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review by Fagery, Mussab, Khorshidi, Hadi A., Wong, Stephen Q., Vu, Martin, IJzerman, Maarten

    Published in PharmacoEconomics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing: System Dynamics Modelling for Integrating MCED Tests with Standard Screening

    Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing: System Dynamics Modelling for Integ... by Fagery, Mussab, Khorshidi, Hadi A., Wong, Stephen Q., Karanfil, Özge, Emery, Jon, IJzerman, Maarten J.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial

    Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial by Glewis, Sarah, Alexander, Marliese, Lingaratnam, Senthil, Lee, Benjamin, Campbell, Ian, Krishnasamy, Mei, IJzerman, Maarten, Fagery, Mussab, Harris, Sam, Georgiou, Chloe, Underhill, Craig, Warren, Mark, Campbell, Robert, Martin, Jennifer, Tie, Jeanne, Michael, Michael

    Published in Acta oncologica
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing

    Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing by Fagery, Mussab, Khorshidi, Hadi A, Wong, Stephen Q, Karanfil, Özge, Emery, Jon, IJzerman, Maarten J

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: